Literature DB >> 10405365

Lymphotoxin-beta-deficient mice show defective antiviral immunity.

D P Berger1, D Naniche, M T Crowley, P A Koni, R A Flavell, M B Oldstone.   

Abstract

Lymphotoxin beta (LTbeta), a member of the tumor necrosis factor family, plays an important role in lymphoid organogenesis. In order to determine whether LTbeta is involved in cellular immunity, we investigated the antiviral immune response of LTbeta-deficient (LTbeta -/-) mice to lymphocytic choriomeningitis virus (LCMV). Cytotoxic T lymphocyte (CTL) responses to LCMV were severely diminished, leading to viral persistence in brain and kidney. However, major functions of LTbeta-deficient T lymphocytes and dendritic cells were intact. Reconstitution of irradiated LTbeta +/+ mice with LTbeta -/- bone marrow induced a disorganized splenic structure, accompanied by impairment of the LCMV-specific CTL response. These data indicate that the absence of LTbeta does not affect the intrinsic function of T lymphocytes or of dendritic cells but that the structural integrity of the spleen is strongly associated with generation of antiviral immunity. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10405365     DOI: 10.1006/viro.1999.9811

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  25 in total

Review 1.  Role of lymphotoxin in experimental models of infectious diseases: potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway.

Authors:  Thomas W Spahn; Hans-Pietro Eugster; Adriano Fontana; Wolfram Domschke; Torsten Kucharzik
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

Review 2.  Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways.

Authors:  Carl F Ware
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

Review 3.  The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games.

Authors:  Thomas Hehlgans; Klaus Pfeffer
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

4.  Role of lymphotoxin alpha in T-cell responses during an acute viral infection.

Authors:  M Suresh; Gibson Lanier; Mary Katherine Large; Jason K Whitmire; John D Altman; Nancy H Ruddle; Rafi Ahmed
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Blockade of interferon Beta, but not interferon alpha, signaling controls persistent viral infection.

Authors:  Cherie T Ng; Brian M Sullivan; John R Teijaro; Andrew M Lee; Megan Welch; Stephanie Rice; Kathleen C F Sheehan; Robert D Schreiber; Michael B A Oldstone
Journal:  Cell Host Microbe       Date:  2015-05-13       Impact factor: 21.023

6.  B cell maintenance of subcapsular sinus macrophages protects against a fatal viral infection independent of adaptive immunity.

Authors:  E Ashley Moseman; Matteo Iannacone; Lidia Bosurgi; Elena Tonti; Nicolas Chevrier; Alexei Tumanov; Yang-Xin Fu; Nir Hacohen; Ulrich H von Andrian
Journal:  Immunity       Date:  2012-03-01       Impact factor: 31.745

7.  Lymphotoxin-alpha-deficient mice can clear a productive infection with murine gammaherpesvirus 68 but fail to develop splenomegaly or lymphocytosis.

Authors:  B J Lee; S Santee; S Von Gesjen; C F Ware; S R Sarawar
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 8.  The Lymphotoxin Network: orchestrating a type I interferon response to optimize adaptive immunity.

Authors:  Jennifer L Gommerman; Jeffrey L Browning; Carl F Ware
Journal:  Cytokine Growth Factor Rev       Date:  2014-03-12       Impact factor: 7.638

9.  Persistent LCMV infection is controlled by blockade of type I interferon signaling.

Authors:  John R Teijaro; Cherie Ng; Andrew M Lee; Brian M Sullivan; Kathleen C F Sheehan; Megan Welch; Robert D Schreiber; Juan Carlos de la Torre; Michael B A Oldstone
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

Review 10.  Lymphotoxin in physiology of lymphoid tissues - Implication for antiviral defense.

Authors:  Ekaterina P Koroleva; Yang-Xin Fu; Alexei V Tumanov
Journal:  Cytokine       Date:  2016-09-09       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.